Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4c6cc38806d44862bca6b02bf708d86d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4c6cc38806d44862bca6b02bf708d86d2021-12-02T10:44:08ZImmunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults10.1038/s41598-021-82606-52045-2322https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82606-5https://doaj.org/toc/2045-2322Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human central nervous system in such disorders is unclear. Here we used liquid chromatography–mass spectrometry to quantify AA, DHA, and EPA derived lipid levels in non-centrifuged cerebrospinal fluid (CSF), centrifuged CSF pellets, and centrifuged CSF supernatants of older adults obtained before, 24 h and 6 weeks after surgery. GAGE analysis was used to determine AA, DHA and EPA metabolite pathway changes over time. Lipid mediators derived from AA, DHA and EPA were detected in all sample types. Postoperative lipid mediator changes were not significant in non-centrifuged CSF (p > 0.05 for all three pathways). The AA metabolite pathway showed significant changes in centrifuged CSF pellets and supernatants from before to 24 h after surgery (p = 0.0000247, p = 0.0155 respectively), from before to 6 weeks after surgery (p = 0.0000497, p = 0.0155, respectively), and from 24 h to 6 weeks after surgery (p = 0.0000499, p = 0.00363, respectively). These findings indicate that AA, DHA, and EPA derived lipids are detectable in human CSF, and the AA metabolite pathway shows postoperative changes in centrifuged CSF pellets and supernatants.Niccolò TerrandoJohn J. ParkMichael DevinneyCliburn ChanMary CooterPallavi AvasaralaJoseph P. MathewQuintin J. QuinonesKrishna Rao MaddipatiMiles Bergerfor the MADCO-PC Study TeamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Niccolò Terrando John J. Park Michael Devinney Cliburn Chan Mary Cooter Pallavi Avasarala Joseph P. Mathew Quintin J. Quinones Krishna Rao Maddipati Miles Berger for the MADCO-PC Study Team Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
description |
Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human central nervous system in such disorders is unclear. Here we used liquid chromatography–mass spectrometry to quantify AA, DHA, and EPA derived lipid levels in non-centrifuged cerebrospinal fluid (CSF), centrifuged CSF pellets, and centrifuged CSF supernatants of older adults obtained before, 24 h and 6 weeks after surgery. GAGE analysis was used to determine AA, DHA and EPA metabolite pathway changes over time. Lipid mediators derived from AA, DHA and EPA were detected in all sample types. Postoperative lipid mediator changes were not significant in non-centrifuged CSF (p > 0.05 for all three pathways). The AA metabolite pathway showed significant changes in centrifuged CSF pellets and supernatants from before to 24 h after surgery (p = 0.0000247, p = 0.0155 respectively), from before to 6 weeks after surgery (p = 0.0000497, p = 0.0155, respectively), and from 24 h to 6 weeks after surgery (p = 0.0000499, p = 0.00363, respectively). These findings indicate that AA, DHA, and EPA derived lipids are detectable in human CSF, and the AA metabolite pathway shows postoperative changes in centrifuged CSF pellets and supernatants. |
format |
article |
author |
Niccolò Terrando John J. Park Michael Devinney Cliburn Chan Mary Cooter Pallavi Avasarala Joseph P. Mathew Quintin J. Quinones Krishna Rao Maddipati Miles Berger for the MADCO-PC Study Team |
author_facet |
Niccolò Terrando John J. Park Michael Devinney Cliburn Chan Mary Cooter Pallavi Avasarala Joseph P. Mathew Quintin J. Quinones Krishna Rao Maddipati Miles Berger for the MADCO-PC Study Team |
author_sort |
Niccolò Terrando |
title |
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
title_short |
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
title_full |
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
title_fullStr |
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
title_full_unstemmed |
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
title_sort |
immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d |
work_keys_str_mv |
AT niccoloterrando immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT johnjpark immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT michaeldevinney immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT cliburnchan immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT marycooter immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT pallaviavasarala immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT josephpmathew immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT quintinjquinones immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT krishnaraomaddipati immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT milesberger immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults AT forthemadcopcstudyteam immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults |
_version_ |
1718396824459411456 |